Lonapegsomatropin

Lonapegsomatropin, sold under the brand name Skytrofa, is a human growth hormone used for the treatment of growth hormone deficiency.[1] Lonapegsomatropin is a prodrug of somatropin.[1] Lonapegsomatropin was approved for medical use in the United States in August 2021.[1][2][3] Contents 1 Medical uses 2 References 3 Further reading 4 External links Medical uses Lonapegsomatropin is a growth hormone therapy ... [wikipedia]